| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Guyer William is a Chief Development Officer at CORCEPT THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $117K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 14 | $71.77 | $1,004.78 | -0.3% | +5.3% | - | |
| Jul 18, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 4,879 | $73.48 | $358,494.74 | -30.8% | +12.2% | - | |
| Jul 1, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 100 | $73.51 | $7,350.50 | -1.8% | +21.1% | - | |
| Jun 10, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 20,000 | $72.42 | $1,448,474.57 | -58.7% | -1.4% | - | |
| May 16, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 32,262 | $74.17 | $2,393,014.49 | -85.5% | -4.1% | - | |
| May 6, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 7,060 | $74.31 | $524,652.60 | -56.3% | +1.5% | -27.3% | |
| Apr 1, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 678 | $114.51 | $77,639.00 | -11.0% | -20.2% | -54.3% | |
| Mar 4, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 20,000 | $59.07 | $1,181,400.00 | -78.5% | +28.0% | -36.2% | |
| Nov 4, 2024 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 10,000 | $48.97 | $489,700.00 | -46.3% | +32.9% | +42.0% | |
| Oct 1, 2024 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 10,000 | $46.28 | $462,800.00 | -63.3% | +8.8% | +80.2% |